PharmacovigilanceOfficial

CMS issues CY 2027 Home Health Prospective Payment System final rule

🇺🇸 CMS · Wed 04 Nov 2026

The US Centers for Medicare & Medicaid Services published final rule CMS-1844-F on 4 November 2026, setting annual Medicare payment policy updates for home health agencies.

The US Centers for Medicare & Medicaid Services (CMS) issued the calendar year 2027 Home Health Prospective Payment System final rule on 4 November 2026. The rule is designated CMS-1844-F.

The final rule sets the yearly Medicare payment policy updates that apply to home health agencies. The source material available to VigiEye does not include the full text, so the specific payment rates, adjustments and policy changes are not covered here.

The only detail visible in the excerpt is a reference to a Medicare provider enrollment section within the rule. No information on its content or scope was provided.

As context, prospective payment systems pay providers predetermined rates for defined units of care rather than reimbursing costs after the fact. Home health agencies are the main audience for this rule. It has little direct bearing on pharmacovigilance or product safety.

What it means for your team

  • Home health providers and their advisers should review the full CMS-1844-F text for the payment and enrollment provisions, as this summary does not describe them.
  • Market-access teams with an interest in home-based care in the US may wish to monitor the rule for downstream reimbursement effects, though none are specified in the source.
  • Pharmacovigilance and product safety teams are unlikely to face direct obligations from this reimbursement-focused rule.

Official source: CMS ↗

Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.

More Pharmacovigilance All →